These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 9333046)

  • 1. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Nordmann P; Ronco E; Naas T; Duport C; Michel-Briand Y; Labia R
    Antimicrob Agents Chemother; 1993 May; 37(5):962-9. PubMed ID: 8517722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic structure associated with blaOXA-18, encoding a clavulanic acid-inhibited extended-spectrum oxacillinase.
    Naas T; Namdari F; Bogaerts P; Huang TD; Glupczynski Y; Nordmann P
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3898-904. PubMed ID: 18663027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.
    Poirel L; Girlich D; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2001 Feb; 45(2):447-53. PubMed ID: 11158739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.
    Danel F; Hall LM; Gur D; Livermore DM
    Antimicrob Agents Chemother; 1997 Apr; 41(4):785-90. PubMed ID: 9087490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and biochemical characterization of OXA-45, an extended-spectrum class 2d' beta-lactamase in Pseudomonas aeruginosa.
    Toleman MA; Rolston K; Jones RN; Walsh TR
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2859-63. PubMed ID: 12936985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of OXA-20, a novel class D beta-lactamase, and its integron from Pseudomonas aeruginosa.
    Naas T; Sougakoff W; Casetta A; Nordmann P
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2074-83. PubMed ID: 9687410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.
    Poirel L; Naas T; Nicolas D; Collet L; Bellais S; Cavallo JD; Nordmann P
    Antimicrob Agents Chemother; 2000 Apr; 44(4):891-7. PubMed ID: 10722487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosa.
    Poirel L; Brinas L; Verlinde A; Ide L; Nordmann P
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3743-8. PubMed ID: 16127048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates.
    Danel F; Hall LM; Gur D; Livermore DM
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3117-22. PubMed ID: 9835501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
    Silva J; Aguilar C; Ayala G; Estrada MA; Garza-Ramos U; Lara-Lemus R; Ledezma L
    Antimicrob Agents Chemother; 2000 Apr; 44(4):997-1003. PubMed ID: 10722503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa 802.
    Rejiba S; Limam F; Belhadj C; Belhadj O; Ben-Mahrez K
    Microb Drug Resist; 2002; 8(1):9-13. PubMed ID: 12002654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXA-46, a new class D beta-lactamase of narrow substrate specificity encoded by a blaVIM-1-containing integron from a Pseudomonas aeruginosa clinical isolate.
    Giuliani F; Docquier JD; Riccio ML; Pagani L; Rossolini GM
    Antimicrob Agents Chemother; 2005 May; 49(5):1973-80. PubMed ID: 15855521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a new β-lactamase OXA-205 from Pseudomonas aeruginosa.
    Krasauskas R; Labeikytė D; Markuckas A; Povilonis J; Armalytė J; Plančiūnienė R; Kavaliauskas P; Sužiedėlienė E
    Ann Clin Microbiol Antimicrob; 2015 Nov; 14():52. PubMed ID: 26611758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
    Hall LM; Livermore DM; Gur D; Akova M; Akalin HE
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1637-44. PubMed ID: 8215276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of the gene into Escherichia coli.
    Nordmann P; Mariotte S; Naas T; Labia R; Nicolas MH
    Antimicrob Agents Chemother; 1993 May; 37(5):939-46. PubMed ID: 8517720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and expression of a cloxacillin-hydrolyzing enzyme and a cephalosporinase from Aeromonas sobria AER 14M in Escherichia coli: requirement for an E. coli chromosomal mutation for efficient expression of the class D enzyme.
    Rasmussen BA; Keeney D; Yang Y; Bush K
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2078-85. PubMed ID: 7811022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
    Hocquet D; Colomb M; Dehecq B; Belmonte O; Courvalin P; Plésiat P; Meziane-Cherif D
    J Antimicrob Chemother; 2011 Aug; 66(8):1745-50. PubMed ID: 21665906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and biochemical characterization of Ambler class A extended-spectrum beta-lactamase CGA-1 from Chryseobacterium gleum.
    Bellais S; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2002 Apr; 46(4):966-70. PubMed ID: 11897576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.